Achieving Viral Suppression in 90% of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities

45Citations
Citations of this article
199Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Although significant progress has been made, the latest data from low- and middle-income countries show substantial gaps in reaching the third "90%" (viral suppression) of the UNAIDS 90-90-90 goals, especially among vulnerable and key populations. This article discusses critical gaps and promising, evidence-based solutions. There is no simple and/or single approach to achieve the last 90%. This will require multifaceted, scalable strategies that engage people living with human immunodeficiency virus, motivate long-term treatment adherence, and are community-entrenched and €'supported, cost-effective, and tailored to a wide range of global communities.

Cite

CITATION STYLE

APA

Nachega, J. B., Sam-Agudu, N. A., Mofenson, L. M., Schechter, M., & Mellors, J. W. (2018, May 2). Achieving Viral Suppression in 90% of People Living with Human Immunodeficiency Virus on Antiretroviral Therapy in Low- and Middle-Income Countries: Progress, Challenges, and Opportunities. Clinical Infectious Diseases. Oxford University Press. https://doi.org/10.1093/cid/ciy008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free